(Q34641738)

3 August 2017

title

Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy (English)

1 reference

3 August 2017

main subject

Neisseria meningitidis

1 reference

1 reference

Miriam Levi

2

0 references

Chiara Azzari

object named as

Chiara Azzari

7

0 references

Paolo Bonanni

8

object named as

Paolo Bonanni

1 reference

3 August 2017

Angela Bechini

1

1 reference

3 August 2017

Sara Boccalini

3

1 reference

3 August 2017

Emilia Tiscione

4

1 reference

3 August 2017

Emanuela Balocchini

5

1 reference

3 August 2017

Clementina Canessa

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

23 August 2012

1 reference

3 August 2017

1 reference

3 August 2017

volume

30

1 reference

3 August 2017

issue

45

1 reference

3 August 2017

page(s)

6396-6401

1 reference

Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Estimation of vaccine effectiveness using the screening method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

EstimatingHaemophilus influenzaeType b Vaccine Effectiveness in England and Wales by Use of the Screening Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.019

10.1016/J.VACCINE.2012.08.019

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference